Rafael Holdings (RFL) EBIT Margin (2017 - 2026)
Rafael Holdings' EBIT Margin was -3837.99% in fiscal Q3 2026 (quarter ended Apr 30, 2026), down 2204.56 percentage points from -1633.43% a year earlier and down 683.96 percentage points from the prior quarter.
Rafael Holdings (RFL) EBIT Margin (2017 - 2026) Analysis & Trends
On a trailing twelve-month basis, Rafael Holdings' EBIT Margin was -3717.24% through Apr 30, 2026, down 952.08 percentage points year-over-year; for FY2025 (ended Jul 31, 2025), it was -3179.83%, up 12931.16 percentage points from FY2024.
- EBIT Margin shows a five-year change of -3007.42 percentage points (FY2020 to FY2025).
- In earlier fiscal years, EBIT Margin was -16110.99% in FY2024 (-10719.23 pp), -5391.76% in FY2023 (+9358.73 pp), -14750.49% in FY2022 (-11234.40 pp) and -3516.08% in FY2021 (-3343.68 pp).
- Quarterly EBIT Margin has moved between -27726.49% (fiscal Q3 2024) and -1633.43% (fiscal Q3 2025) over five years.
- Compared with a year earlier, EBIT Margin was higher in four of the last eight quarters, with an average year-over-year change of +3121.05 percentage points.
- The best year-over-year quarter for EBIT Margin over five years was fiscal Q3 2025 (a gain of 26093.06 percentage points); the worst was fiscal Q1 2022 (a drop of 25699.56 percentage points).
- Per Business Quant data, RFL's EBIT Margin in the three fiscal quarters before Q3 2026 was -3154.03% (Q2 2026), -4225.42% (Q1 2026) and -3646.57% (Q4 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBIT Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 655.56 Bn | 574.09 Bn | 17.26 Bn | 28.21% |
| 2 | AbbVie | 470.94 Bn | 444.10 Bn | 12.70 Bn | 37.86% |
| 3 | Merck | 367.14 Bn | 321.57 Bn | 12.21 Bn | -3.52% |
| 4 | Novartis Ag | 280.33 Bn | 236.20 Bn | 11.24 Bn | 32.97% |
| 5 | Astrazeneca | 257.78 Bn | 231.34 Bn | 12.86 Bn | 20.57% |
| 6 | Amgen | 226.04 Bn | 181.44 Bn | 7.24 Bn | 34.95% |
| 7 | Gilead Sciences | 188.89 Bn | 163.01 Bn | 6.22 Bn | -133.21% |
| 8 | Pfizer | 163.75 Bn | 110.70 Bn | 10.94 Bn | 28.37% |
| 9 | Vertex Pharmaceuticals | 133.68 Bn | 105.69 Bn | 2.84 Bn | 37.40% |
| 10 | Rafael Holdings | 102.93 Mn | 108.34 Mn | 163,000.00 | -3,837.99% |
Historic Data
| Date | Value |
|---|---|
| Apr 30, 2026 | -3,837.99% |
| Jan 31, 2026 | -3,154.03% |
| Oct 31, 2025 | -4,225.42% |
| Jul 31, 2025 | -3,646.57% |
| Apr 30, 2025 | -1,633.43% |
| Jan 31, 2025 | -8,622.08% |
| Oct 31, 2024 | -3,003.13% |
| Jul 31, 2024 | -2,330.30% |
| Apr 30, 2024 | -27,726.49% |
| Jan 31, 2024 | -4,622.06% |
| Oct 31, 2023 | -3,644.12% |
| Jul 31, 2023 | -3,839.71% |
| Apr 30, 2023 | -4,269.01% |
| Jan 31, 2023 | -6,084.29% |
| Oct 31, 2022 | -7,345.71% |
| Jul 31, 2022 | -7,011.59% |
| Apr 30, 2022 | -6,171.05% |
| Jan 31, 2022 | -2,160.81% |
| Oct 31, 2021 | -25,936.13% |
| Apr 30, 2021 | -351.41% |
Rafael Holdings EBIT Margin API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=ebit-margin&ticker=RFL&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "ebit-margin", "ticker": "RFL", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=ebit-margin&ticker=RFL&period=max&api_key=YOUR_API_KEY");
const data = await res.json();